论文部分内容阅读
目的研究消膈汤联合GP方案治疗中晚期食管癌的临床疗效。方法对48例中晚期食管癌患者随机分为治疗组和对照组,治疗组使用消膈汤联合GP方案治疗,对照组使用GP方案化疗。结果消膈汤联合GP方案治疗中晚期食管癌与对照组相比稳定以上率有显著差异,骨髓抑制及不良反应例数对比亦有统计学意义。结论消膈汤联合GP方案治疗中晚期食管癌,疗效显著,值得临床推广应用。
Objective To study the clinical efficacy of Xiaogan Decoction combined with GP regimen in the treatment of advanced esophageal cancer. Methods Forty-eight patients with advanced esophageal cancer were randomly divided into treatment group and control group. The treatment group was treated with Xiaji Decoction combined with GP regimen and the control group with GP regimen. Results The results showed that there was a significant difference in the above rates between the treatment of middle-advanced esophageal cancer and the treatment of middle-late stage esophageal cancer by GPD combined with GP regimen. The number of cases with bone marrow suppression and adverse reactions was also statistically significant. Conclusion Xia decoction combined with GP regimen in the treatment of advanced esophageal cancer has a significant curative effect and is worthy of clinical application.